跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 861 条关于
“SOLARIS”
全部
861
临床试验
758
药物
13
机构
15
资讯
75
去年
Teva's TEV-‘749 Shows Positive Phase 3 Results for Schizophrenia Treatment
去年
Teva's TEV-'749 Shows Promise in Improving Social Functioning in Schizophrenia Patients
去年
Teva's TEV-'749 Shows Promise in Improving Social Functioning in Schizophrenia Patients
2个月前
Phase 3 SOLARIS Trial: Subcutaneous Olanzapine LAI Demonstrates Efficacy Without PDSS in Schizophrenia
去年
Teva's TEV-749 Shows Promise in Schizophrenia Treatment with No PDSS Incidence
21小时前
Teva's Once-Monthly Subcutaneous Olanzapine LAI TEV-'749 Shows High Stabilization and Low Relapse in Phase 3 SOLARIS Post Hoc Data
2年前
Teva and Medincell Announce Positive Phase 3 Efficacy Results for TEV-749 in Schizophrenia Treatment
2年前
High-Dose Vitamin D3 Fails to Improve Outcomes in Metastatic Colorectal Cancer
去年
Teva's TEV-'749 Shows Promise in Improving Social Functioning in Schizophrenia Patients
去年
Teva's TEV-'749 Demonstrates Improved Social Functioning in Schizophrenia Patients
第 1 页,共 8 页
上一页
下一页